Letters sent to healthcare professionals in January 2017

A summary of letters sent to relevant healthcare professionals in January 2017.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 20 February 2017

• Therapeutic area: Cancer, Endocrinology, diabetology and metabolism and Obstetrics, gynaecology and fertility

In January 2017, letters were sent regarding:

• Insuman (human insulin): end of supply shortage (letter to healthcare professionals and letter to patient organisations)
• Mirena (levonorgestrel intrauterine delivery system): batch insertion tube defect
• Ulipristal acetate (ellaOne): pregnancy registry
• ERWINASE: notice of special handling instructions—vials of ERWINASE from batch 180G should be used with a 5-micron filter needle
• DepoCyte (cytarabine): temporary supply issue

Article citation: Drug Safety Update volume 10 issue 7, February 2017: 3.

Published 20 February 2017